Cancer drug prices higher in U.S., yet relatively affordable
Sunday, June 12, 2016
Even though U.S. drug prices are higher than in other countries, that does not necessarily mean medicines are less affordable here. A study of cancer drug prices in six countries around the world, presented at the American Society of Clinical Oncology meeting, challenged the view that cost is a bigger barrier to access in the U.S. than elsewhere. David Nanus, M.D., discusses the findings with MedPage Today.
